Xenon Pharmaceuticals Inc. - Common Stock (XENE)

CUSIP: 98420N105

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / Common Stock
Shares outstanding
76,851,274
Total 13F shares
28,020,659
Share change
-361,255
Total reported value
$430,912,842
Price per share
$15.38
Number of holders
79
Value change
-$1,905,185
Number of buys
31
Number of sells
27

Quarterly Holders Quick Answers

What is CUSIP 98420N105?
CUSIP 98420N105 identifies XENE - Xenon Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Xenon Pharmaceuticals Inc. - Common Stock (XENE) as of Q4 2020

As of 31 Dec 2020, Xenon Pharmaceuticals Inc. - Common Stock (XENE) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 28,020,659 shares. The largest 10 holders included BVF INC/IL, Avoro Capital Advisors LLC, FMR LLC, ORBIMED ADVISORS LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., Capital International Investors, EVENTIDE ASSET MANAGEMENT, LLC, NEA Management Company, LLC, Capital World Investors, and Bank of New York Mellon Corp. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.